ODX.L Share News (ODX)

Omega Diagnostics reports good progress in infectious disease division

AIM-listed medical diagnostics company Omega has cheered with news of its infectious disease and allergy projects. Within infectious disease it has made three pilot batches of test devices all of which have shown that its Visitect CD4 product is capable of meeting its performance design goals in com

LONDON MIDDAY BRIEFING: Lloyds Buoyed By Latest Share Sale News

WINNERS & LOSERS: Playtech Falls After Plus500 Acquisition Agreement

Omega Diagnostics Making Progress On Visitect, Allersys Development

Omega Diagnostics Appoints Colin King Chief Operating Officer

LONDON MIDDAY BRIEFING: FTSE 100 Hits A New Record High

WINNERS & LOSERS: Fresnillo Leads FTSE 100 On Strong Production Update

Omega Diagnostics generates alpha with encouraging update

Shares in Omega Diagnostics were seen as a better investment on Wednesday after a trading update indicated full-year results will be ahead of target and revealed encouraging developments with the product portfolio. The AIM-listed company believes it has identified the cause of the manufacturing vari

Omega Diagnostics Expects To Meet Market Expectations, Shares Higher

UK MORNING BRIEFING: Tesco And BT Lead Fallers In Cautious Market

Omega Diagnostics Shares Drop As It Warns On Visitect CD4 Setbacks

UK MORNING BRIEFING: CSR Soars On Bid Report; Xaar Falls On Outlook

Omega Diagnostics develops new app for health services partnership

Omega Diagnostics has helped form a new group to connect the mobile and health industries to help meet public health needs in rural areas. As part of the Groupe Speciale Mobile Association (GSMA), Omega can offer use of its mobile app, CD4, to transmit HIV test results from remote villages in Sub-S

Omega Diagnostics Agrees Sub-Saharan Africa Collaboration

UK MIDDAY BRIEFING: ASOS Hit By Suspicious Warehouse Fire